MediWound Ltd. (MDWD) 追踪市盈率为负值 -9.3, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 24.3 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -10.72%, 前瞻盈利收益率 4.12%. PEG 0.09 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
SharesGrow 综合评分： 42/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -5.3 | 0.35 | 12.88 | 64.24 | - |
| 2017 | -4.8 | -0.49 | 11.04 | 42.54 | - |
| 2018 | -104.1 | 1.09 | 12.27 | 32.36 | - |
| 2019 | 17.0 | -0.03 | 5.55 | 2.65 | - |
| 2020 | -10.9 | 0.04 | 13.84 | 4.63 | - |
| 2021 | -4.7 | -0.10 | -14.03 | 2.71 | - |
| 2022 | -3.4 | -0.27 | 6.16 | 2.54 | - |
| 2023 | -13.6 | 0.17 | 2.90 | 4.91 | - |
| 2024 | -5.9 | -0.02 | 5.69 | 8.77 | - |
| 2025 | -8.8 | 0.29 | 4.81 | 12.38 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-6.05 | $1.56M | $-18.89M | -1212.1% |
| 2017 | $-6.64 | $2.5M | $-22.15M | -887.4% |
| 2018 | $-0.28 | $3.4M | $-1.06M | -31.1% |
| 2019 | $1.26 | $31.79M | $4.96M | 15.6% |
| 2020 | $-2.38 | $21.76M | $-9.2M | -42.3% |
| 2021 | $-3.48 | $23.76M | $-13.55M | -57% |
| 2022 | $-3.93 | $26.5M | $-19.6M | -74% |
| 2023 | $-0.75 | $18.69M | $-6.72M | -35.9% |
| 2024 | $-3.03 | $20.22M | $-30.22M | -149.5% |
| 2025 | $-2.10 | $16.96M | $-23.88M | -140.8% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-2.75 | $-3.31 – $-2.11 | $24.76M | $24.08M – $25.32M | 5 |
| 2027 | $-2.04 | $-2.62 – $-1.40 | $33.44M | $32.49M – $34.46M | 5 |
| 2028 | $-1.24 | $-1.51 – $-0.72 | $53.59M | $52.08M – $55.04M | 3 |
| 2029 | $0.71 | $0.68 – $0.74 | $109.36M | $106.28M – $112.32M | 1 |
| 2030 | $2.73 | $2.63 – $2.83 | $181.41M | $176.32M – $186.33M | 1 |
